EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sedative and cardiopulmonary effects of medetomidine and butorphanol, with or without vatinoxan, in puppies - randomised, blinded clinical trial

Vuokko I E Pekkola, Jaan Lepajõe, Anna-Mariam Kiviranta, Kati M Salla, Marja R Raekallio, Ira J Kallio-Kujala

Veterinary Anaesthesia and Analgesia · 2026

DOI: 10.1016/j.vaa.2026.101283 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Anaesthesia and Analgesia, 2026. Verfasst von Vuokko I E Pekkola und 5 weiteren Autor:innen. Beteiligte Einrichtung: Small Animal Hospital, Veterinary Teaching Hospital, University of Helsinki, Finland; Department of Equine and Small Animal Medicine, University of H…. Hauptthemen laut MEDLINE: Butorphanol, Hypnotics and Sedatives, Medetomidine, Quinolizines. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetcare Oy, Eläinlääketieteen Tutkimuksen Tukisäätiö.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To explore efficacy and cardiopulmonary effects of medetomidine and butorphanol, with or without vatinoxan, in healthy puppies. STUDY DESIGN: Randomised, blinded clinical trial. ANIMALS: A group of healthy client-owned puppies aged between 42 and 51 days scheduled for elective brainstem auditory-evoked response (BAER) testing. METHODS: Puppies were randomised within each litter to the following two groups: MB (n = 16; medetomidine hydrochloride 10 μg kg-1 and butorphanol 0.2 mg kg-1) or MVB (n = 16; medetomidine hydrochloride 10 μg kg-1, vatinoxan hydrochloride 0.2 mg kg-1, and butorphanol 0.2 mg kg-1). Drugs were injected intramuscularly. Pulse rate (PR), arterial blood haemoglobin oxygen saturation (SpO2) and mean arterial blood pressure (MAP) were measured noninvasively every 5 minutes. Sedation depth was assessed with a multidimensional scoring system. Following BAER testing, sedation was reversed with intramuscular atipamezole hydrochloride 25 μg kg-1. Linear mixed models were created to investigate the effects of time and treatment group on PR and MAP. RESULTS: All puppies were sufficiently sedated for BAER testing within 5 minutes after treatment. PR was significantly higher and MAP significantly lower with MVB than with MB 5 to 15 minutes after drug injection (p ≤ 0.001). PR nadir was detected at 5 minutes after both treatments (109 ± 15 beats minute-1 and 142 ± 28 beats minute-1 with MB and MVB, respectively). No hypotension (MAP < 60 mmHg) was detected in any animal. The most common complication during sedation was hypoxaemia (SpO2 < 95%), observed in 18/32 puppies when breathing room air. Hypoxaemia resolved with supplemental oxygen. Recoveries from sedation were uneventful. CONCLUSIONS AND CLINICAL RELEVANCE: Medetomidine-butorphanol is an effective combination for sedation of puppies. Adding vatinoxan maintains higher PR. Provision of supplemental oxygen during sedation is recommended.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ButorphanolHypnotics and SedativesMedetomidineQuinolizinesAnimalsDogsFemaleMaleBlood PressureDrug Therapy, CombinationHeart Rate

Stichwörter der Autor:innen

alpha2-agonistalpha2-antagonistpaediatric dogsedation

Substanzen

ButorphanolHypnotics and SedativesMedetomidineQuinolizinesvatinoxan

Autor:innen und Institutionen

  • Small Animal Hospital, Veterinary Teaching Hospital, University of Helsinki, Finland; Department of Equine and Small Animal Medicine, University of Helsinki, Finland. Electronic address: vuokko.pekkola@helsinki.fi.
  • Small Animal Hospital, Veterinary Teaching Hospital, University of Helsinki, Finland.
  • Department of Equine and Small Animal Medicine, University of Helsinki, Finland.

Förderung

  • Vetcare Oy
  • Eläinlääketieteen Tutkimuksen Tukisäätiö

Zitieren

APA

Pekkola, V. I. E., Lepajõe, J., Kiviranta, A. M., Salla, K. M., Raekallio, M. R., & Kallio-Kujala, I. J. (2026). Sedative and cardiopulmonary effects of medetomidine and butorphanol, with or without vatinoxan, in puppies - randomised, blinded clinical trial. Veterinary Anaesthesia and Analgesia. https://doi.org/10.1016/j.vaa.2026.101283

Vancouver

Pekkola VIE, Lepajõe J, Kiviranta AM, Salla KM, Raekallio MR, Kallio-Kujala IJ. Sedative and cardiopulmonary effects of medetomidine and butorphanol, with or without vatinoxan, in puppies - randomised, blinded clinical trial. Veterinary Anaesthesia and Analgesia. 2026. doi:10.1016/j.vaa.2026.101283

BibTeX
@article{Pekkola2026,
  author = {Pekkola, Vuokko I E and Lepajõe, Jaan and Kiviranta, Anna-Mariam and Salla, Kati M and Raekallio, Marja R and Kallio-Kujala, Ira J},
  title = {Sedative and cardiopulmonary effects of medetomidine and butorphanol, with or without vatinoxan, in puppies - randomised, blinded clinical trial},
  journal = {Veterinary Anaesthesia and Analgesia},
  year = {2026},
  doi = {10.1016/j.vaa.2026.101283}
}
Kostenlos starten →